IP Library Granted Patent US 7,960,459
Granted Patent B2
US 7,960,459 · App. 12/279,466 · Granted Jun 14, 2011

Curable composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,459
App. No.
12/279,466
Granted
Jun 14, 2011
Kind
B2
Abstract

The present invention has its object to provide a curable composition which comprises a reactive silyl group-containing organic polymer, does not contain, as a silanol condensation catalyst, any organotin type curing catalyst currently of concern because of the toxic feature thereof, is excellent in surface curability and depth curability and, further, can provide cured products excellent in adhesiveness; the above object can be achieved by a curable composition which comprises: an organic polymer (A) containing a silicon-containing group capable of crosslinking under siloxane bond formation; and a guanidine compound (B-1), as a silanol condensation catalyst (B), represented by the general formula (1): R 1 N═C(NR 1 2 ) 2   (1) (wherein one of the five R 1 s is an aryl group and the other four R 1 s each independently is a hydrogen atom or a hydrocarbon group in which the carbon atom at position 1 is saturated).

Claims (13)

1. A curable composition which comprises:

an organic polymer (A) containing a silicon-containing group capable of crosslinking under siloxane bond formation; and

a guanidine compound (B-1), as a silanol condensation catalyst (B), represented by the general formula (3):

wherein the a R 2 s each independently is a hydrogen atom, a halogen atom, a hydroxyl group, an amino group, a nitro group, a cyano group, a sulfonic acid group, or an organic group; and a is an integer of 0 to 5.

2. The curable composition according to claim 1 , wherein the guanidine compound (B-1) is 1-phenylguanidine and/or 1-(o-tolyl)guanidine.

3. The curable composition according to claim 1 , wherein the main chain skeleton of the organic polymer (A) comprises at least one selected from among a hydrogen atom, a carbon atom, a nitrogen atom, an oxygen atom and a sulfur atom.

4. The curable composition according to claim 1 , wherein the main chain skeleton of the organic polymer (A) comprises at least one selected from the group consisting of polyoxyalkylene polymers, saturated hydrocarbon polymers and (meth)acrylate ester polymers.

5. The curable composition according to claim 4 , wherein the polyoxyalkylene polymer is a polyoxypropylene polymer.

6. The curable composition according to claim 1 , which contains the guanidine compound (B-1) in an amount of 0.001 to 20 parts by weight per 100 parts by weight of the organic polymer (A).

7. The curable composition according to claim 1 , which contains an organic acid as the component (C) in an amount of 0.001 to 20 parts by weight per 100 parts by weight of the organic polymer (A).

8. The curable composition according to claim 1 , which contains a titanium compound and/or an aluminum compound as the component (D) in an amount of 0.001 to 20 parts by weight per 100 parts by weight of the organic polymer (A).

9. A sealant which comprises the curable composition according to claim 1 .

10. An adhesive which comprises the curable composition according to claim 1 .

Assignments (2)
CHANGE OF ADDRESS Recorded Jan 15, 2014
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 032019/0901 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2009
From: NORO, NORIKO; OKAMOTO, TOSHIHIKO; YANO, AYAKO; MORII, YOSHIKAZU
To: KANEKA CORPORATION
Reel/Frame 022070/0360 →